Naropin Injection, Solution
Product Images NDC 63323-288

Naropin® (ropivacaine HCl Injection, USP) is a prescription medication used for nerve block and epidural procedures. Each milliliter of Naropin® contains 2mg of Ropivacaine HCI and Sodium chloride. The solution does not contain preservatives, and users are advised to consult the package insert for dosage and full prescribing information. It is important not to use Naropin® if the solution appears discolored or contains a precipitate. This medication should be stored at 68°F to 77°F, and the container closure is not made with natural rubber latex. However, the above text contains errors, the correct text should contain the expression "Consult package insert for dosage and full prescribing information", and the last line "Mid.by." is also an error. The correct line is "Lake Zurich, IL 60047, Fresenius Kabi".*

This is a product description for Naropin, which is an injection containing ropivacaine HCI. It has a strength of 0.5% S and is manufactured by Fresenius Kabi. The packaging does not contain natural rubber latex, and it is kept at controlled room temperature. The product is only available with a prescription, and Novaplus is a registered trademark of Vizient Inc.*

Naropin (Ropivacaine HCl Injection, USP) is a solution for Infiltration, Nerve Block, and Epidural Administration supplied in a pack of 25 single dose vials, and not for Intravenous Administration. Its composition of each mL includes Ropivacaine HCI 5 mg, Sodium chloride 8 mg, Sodium hydroxide and/or hydrochloric acid to adjust the pH104.010 6.0. The solution is preservative-free and the unused portion should be discarded. The container closure is not made with natural rubber latex. This product is manufactured by Fresenius Kabi. For dosage and complete prescribing information, please consult the package insert.*

Naropin® (ropivacaine HCI Injection, USP) is a medication that comes in a single-dose vial with 200 mg per 20 mL. It is intended for epidural administration only and should not be administered intravenously. The medication should be stored at 20° to 25°C and is a trademark of Fresenius Kabi USA, LLC. Novaplus is a registered trademark of Vizient, Inc. The medication is manufactured by Fresenius Kabi and has lot number 3 402796C.*